Asia-Pacific Neuromodulation Devices Market Outlook to 2033 – Implantable Neuromodulation Devices and Non-Invasive Neuromodulation Devices

All the vital news, analysis, and commentary curated by our industry experts.

$5995

Buy Report

Published: April 27, 2026 Report Code: GDME21760CRDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “Asia-Pacific Neuromodulation Devices Outlook to 2033” is a comprehensive databook report, covering key market data on the Asia-Pacific Neuromodulation Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Implantable Neuromodulation Devices, Minimally Invasive Neuromodulation Devices and Non-Invasive Neuromodulation Devices

The Asia-Pacific Neuromodulation Devices Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2025 company share data for Neuromodulation Devices Market.
• Global corporate-level profiles of key companies operating within the Asia-Pacific Neuromodulation Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Asia-Pacific Neuromodulation Devices is segmented as follows:

• Implantable Neuromodulation Devices

• Minimally Invasive Neuromodulation Devices

• Non-Invasive Neuromodulation Devices

Reasons to Buy

The Asia-Pacific Neuromodulation Devices Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Medtronic Plc
Boston Scientific Corp
LivaNova Plc
Abbott Laboratories
Nevro Corp
Beijing Pins Medical Co Ltd
Enterra Medical Inc

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Neuromodulation Devices Market Segmentation

2.3 Definitions of Markets Covered in the Report

3 Neuromodulation Devices Market, Asia-Pacific

3.1 Neuromodulation Devices Market, Asia-Pacific, Revenue ($m), 2018-2033

3.2 Neuromodulation Devices Market, Asia-Pacific, Revenue ($m), 2018-2033

3.3 Neuromodulation Devices Market, Asia-Pacific, Volume (Units), 2018-2033

3.4 Neuromodulation Devices Market, Asia-Pacific, Volume (Units), 2018-2033

3.5 Neuromodulation Devices Market, Asia-Pacific, Company Share by Revenue ($m), 2025

4 Neuromodulation Devices Market, Australia

4.1 Neuromodulation Devices Market, Australia, Revenue ($m), 2018-2033

4.1.1 Implantable Neuromodulation Devices Market, Australia, Revenue ($m), by Segment, 2018-2033

4.2 Neuromodulation Devices Market, Australia, Volume (Units), 2018-2033

4.2.1 Implantable Neuromodulation Devices Market, Australia, Volume (Units), by Segment, 2018-2033

4.3 Neuromodulation Devices Market, Australia, Average Price ($), 2018-2033

4.4 Neuromodulation Devices Market, Australia, Company Share by Revenue ($m), 2025

5 Neuromodulation Devices Market, China

5.1 Neuromodulation Devices Market, China, Revenue ($m), 2018-2033

5.1.1 Implantable Neuromodulation Devices Market, China, Revenue ($m), by Segment, 2018-2033

5.2 Neuromodulation Devices Market, China, Volume (Units), 2018-2033

5.2.1 Implantable Neuromodulation Devices Market, China, Volume (Units), by Segment, 2018-2033

5.3 Neuromodulation Devices Market, China, Average Price ($), 2018-2033

5.4 Neuromodulation Devices Market, China, Company Share by Revenue ($m), 2025

6 Neuromodulation Devices Market, India

6.1 Neuromodulation Devices Market, India, Revenue ($m), 2018-2033

6.1.1 Implantable Neuromodulation Devices Market, India, Revenue ($m), by Segment, 2018-2033

6.2 Neuromodulation Devices Market, India, Volume (Units), 2018-2033

6.2.1 Implantable Neuromodulation Devices Market, India, Volume (Units), by Segment, 2018-2033

6.3 Neuromodulation Devices Market, India, Average Price ($), 2018-2033

6.4 Neuromodulation Devices Market, India, Company Share by Revenue ($m), 2025

7 Neuromodulation Devices Market, Japan

7.1 Neuromodulation Devices Market, Japan, Revenue ($m), 2018-2033

7.1.1 Implantable Neuromodulation Devices Market, Japan, Revenue ($m), by Segment, 2018-2033

7.2 Neuromodulation Devices Market, Japan, Volume (Units), 2018-2033

7.2.1 Implantable Neuromodulation Devices Market, Japan, Volume (Units), by Segment, 2018-2033

7.3 Neuromodulation Devices Market, Japan, Average Price ($), 2018-2033

7.4 Neuromodulation Devices Market, Japan, Company Share by Revenue ($m), 2025

8 Neuromodulation Devices Market, South Korea

8.1 Neuromodulation Devices Market, South Korea, Revenue ($m), 2018-2033

8.1.1 Implantable Neuromodulation Devices Market, South Korea, Revenue ($m), by Segment, 2018-2033

8.2 Neuromodulation Devices Market, South Korea, Volume (Units), 2018-2033

8.2.1 Implantable Neuromodulation Devices Market, South Korea, Volume (Units), by Segment, 2018-2033

8.3 Neuromodulation Devices Market, South Korea, Average Price ($), 2018-2033

8.4 Neuromodulation Devices Market, South Korea, Company Share by Revenue ($m), 2025

9 Overview of Key Companies in Asia-Pacific Neuromodulation Devices Market

9.1 Medtronic Plc

9.1.1 Company Overview

9.2 Boston Scientific Corp

9.2.1 Company Overview

9.3 LivaNova Plc

9.3.1 Company Overview

9.4 Abbott Laboratories

9.4.1 Company Overview

9.5 Nevro Corp

9.5.1 Company Overview

9.6 Beijing Pins Medical Co Ltd

9.6.1 Company Overview

9.7 Enterra Medical Inc

9.7.1 Company Overview

10 Neuromodulation Devices Market Pipeline Products

11 Recent Developments

11.1 Corporate Communications

11.1.1 Nov 18, 2025: NeuroSigma Launches Next-Generation Monarch Device for Pediatric ADHD

11.1.2 Nov 11, 2025: Novel Technique Enhances Brain-State Detection

11.1.3 Nov 06, 2025: Synchron Secures $200 Million Series D Funding for Brain-Computer Interface Development

11.1.4 Oct 10, 2025: Nexalin Technology Attends the 2025 Maxim Growth Summit

11.1.5 Oct 06, 2025: GSK Appoints Luke Miels As CEO Designate

11.1.6 Sep 09, 2025: Pioneering Sustainability: Teijin Carbon Publishes Its First Sustainability Report

11.2 Financial Announcements

11.2.1 Feb 05, 2026: Nihon Kohden Announces Consolidated Financial Results for the Third Quarter of FY2025 ending March 31, 2026

11.2.2 Oct 14, 2025: FPH to Announce Half Year Results on 26 November 2025

11.2.3 Aug 05, 2025: Teijin Reports Results for Three Months Ended June 30, 2025

11.3 Government and Public Interest

11.3.1 Nov 07, 2025: Empowering National Medical Device Innovation and Promoting Industry Integration

11.3.2 Oct 10, 2025: Nexalin Technology Attends the 2025 Maxim Growth Summit

11.4 Other Significant Developments

11.4.1 Nov 24, 2025: NeuroPace Announces Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services

11.4.2 Nov 07, 2025: Empowering National Medical Device Innovation and Promoting Industry Integration

11.4.3 Sep 29, 2025: PolyU And Zhejiang Qiangnao Technology Sign MOU To Explore Joint Research Centre For Brain-Computer Interface

11.5 Product News

11.5.1 Nov 28, 2025: Yale-Trained Neuroscientist Introduces Panbrain Lume "Digital Sunshine" Device to Improve Sleep

11.5.2 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV

11.5.3 Nov 21, 2025: Brainbox and Sonic Concepts Deliver 100 NeuroFUS Systems Worldwide

11.5.4 Nov 15, 2025: Evidence Builds for Disrupted Mitochondria as Cause of Parkinson’s

11.5.5 Nov 06, 2025: Synchron Secures $200 Million Series D Funding for Brain-Computer Interface Development

11.5.6 Nov 05, 2025: Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for Alzheimer’s Treatment

11.5.7 Oct 30, 2025: Nexalin Technology Receives Regulatory Approval for Gen 2 SYNC Neurostimulation Device in Israel

11.5.8 Oct 30, 2025: Sant Pau Incorporates MRgFUS Technology For Movement Disorders Without Surgery

11.5.9 Oct 24, 2025: IDE Group Announces Winner of the 2025 Building Better Futures for Health Challenge

11.5.10 Oct 21, 2025: Nexalin’s DIFS Neurostimulation Demonstrates Cognitive Improvements in Alzheimer’s and Dementia

11.5.11 Oct 20, 2025: Neupulse Attends Launch of N3 Centre for Neurotechnology

11.5.12 Oct 08, 2025: Nexalin Technology Reports Positive Clinical Results for Alzheimer’s with Gen-2 SYNC Device

11.5.13 Oct 07, 2025: Oxeia Biopharmaceuticals Recognized As Most Innovative Mild Traumatic Brain Injury Company for 2025

11.5.14 Oct 01, 2025: BalanceWear® for Multiple Sclerosis: Enhance Stability and Mobility

11.5.15 Sep 29, 2025: Development of a Wireless Multifunctional Brain Oxygen Monitor for Rehabilitation and Daily Use

11.5.16 Sep 25, 2025: Nexalin Technology Issues U.S. Patent for HALO Clarity Device with DIFS Technology

11.5.17 Sep 17, 2025: Soft Bioelectronic Fiber Tracks Hundreds of Biological Events Simultaneously

11.5.18 Sep 10, 2025: Robotimize Showcases Hospital-to-Community Neurorehabilitation at AOCNR 2025 in Yogyakarta

11.5.19 Sep 10, 2025: Neurocare Group's Apollo TMS Therapy Devices Granted FDA Clearance for Treating Adolescent Depression

11.5.20 Mar 03, 2025: KYOCERA to Showcase Ceramic Lab Analytic Technologies for Multilayer Direct Bonding, Ceramic Additive Manufacturing, and Sapphire Apertures at Pittcon 2025

11.6 Research And Development

11.6.1 Sep 29, 2025: Development of a Wireless Multifunctional Brain Oxygen Monitor for Rehabilitation and Daily Use

11.7 Strategy And Business Planning

11.7.1 Nov 25, 2025: NaviFUS Presents Stroke Rehabilitation Data at AOCCN 2025

11.7.2 Nov 21, 2025: Brainbox and Sonic Concepts Deliver 100 NeuroFUS Systems Worldwide

11.7.3 Nov 13, 2025: Nexalin Technology Appoints Carmi Masha Technologies Ltd. As Exclusive Distributor In Israel

11.7.4 Nov 06, 2025: Synchron Secures $200 Million Series D Funding for Brain-Computer Interface Development

11.7.5 Oct 30, 2025: Nexalin Technology Receives Regulatory Approval for Gen 2 SYNC Neurostimulation Device in Israel

11.7.6 Oct 20, 2025: Neupulse Attends Launch of N3 Centre for Neurotechnology

11.7.7 Sep 29, 2025: PolyU And Zhejiang Qiangnao Technology Sign MOU To Explore Joint Research Centre For Brain-Computer Interface

12 Appendix

12.1 Research Methodology

12.1.1 Coverage

12.1.2 Secondary Research

12.1.3 Primary Research

12.1.4 Market Modeling and Forecasting

12.1.5 Company Share Analysis

12.1.6 Benchmarking

12.2 GlobalData Consulting

12.3 Contact Us

12.4 Disclaimer

Table

Table 1: Neuromodulation Devices Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033

Table 2: Neuromodulation Devices Market, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033

Table 3: Neuromodulation Devices Market, Asia-Pacific, Volume (Units), 2018-2033

Table 4: Neuromodulation Devices Market, Asia-Pacific, Volume (Units), 2018-2033

Table 5: Neuromodulation Devices Market, Asia-Pacific, Company Share by Revenue ($m), 2025

Table 6: Neuromodulation Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033

Table 7: Implantable Neuromodulation Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033

Table 8: Neuromodulation Devices Market, Australia, Volume (Units), 2018-2033

Table 9: Implantable Neuromodulation Devices Market, Australia, Volume (Units), 2018-2033

Table 10: Neuromodulation Devices Market, Australia, Average Price ($), 2018-2033

Table 11: Neuromodulation Devices Market, Australia, Company Share by Revenue ($m), 2025

Table 12: Neuromodulation Devices Market, China, Revenue ($m), USD Constant, 2018-2033

Table 13: Implantable Neuromodulation Devices Market, China, Revenue ($m), USD Constant, 2018-2033

Table 14: Neuromodulation Devices Market, China, Volume (Units), 2018-2033

Table 15: Implantable Neuromodulation Devices Market, China, Volume (Units), 2018-2033

Table 16: Neuromodulation Devices Market, China, Average Price ($), 2018-2033

Table 17: Neuromodulation Devices Market, China, Company Share by Revenue ($m), 2025

Table 18: Neuromodulation Devices Market, India, Revenue ($m), USD Constant, 2018-2033

Table 19: Implantable Neuromodulation Devices Market, India, Revenue ($m), USD Constant, 2018-2033

Table 20: Neuromodulation Devices Market, India, Volume (Units), 2018-2033

Table 21: Implantable Neuromodulation Devices Market, India, Volume (Units), 2018-2033

Table 22: Neuromodulation Devices Market, India, Average Price ($), 2018-2033

Table 23: Neuromodulation Devices Market, India, Company Share by Revenue ($m), 2025

Table 24: Neuromodulation Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033

Table 25: Implantable Neuromodulation Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033

Table 26: Neuromodulation Devices Market, Japan, Volume (Units), 2018-2033

Table 27: Implantable Neuromodulation Devices Market, Japan, Volume (Units), 2018-2033

Table 28: Neuromodulation Devices Market, Japan, Average Price ($), 2018-2033

Table 29: Neuromodulation Devices Market, Japan, Company Share by Revenue ($m), 2025

Table 30: Neuromodulation Devices Market, South Korea, Revenue ($m), USD Constant, 2018-2033

Table 31: Implantable Neuromodulation Devices Market, South Korea, Revenue ($m), USD Constant, 2018-2033

Table 32: Neuromodulation Devices Market, South Korea, Volume (Units), 2018-2033

Table 33: Implantable Neuromodulation Devices Market, South Korea, Volume (Units), 2018-2033

Table 34: Neuromodulation Devices Market, South Korea, Average Price ($), 2018-2033

Table 35: Neuromodulation Devices Market, South Korea, Company Share by Revenue ($m), 2025

Table 36: Neuromodulation Devices Market Pipeline Products

Table 37: Total Number of Primary Research Participants, Neurology Devices Market, by Country

Figures

Figure 1: Neuromodulation Devices Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033

Figure 2: Neuromodulation Devices Market, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033

Figure 3: Neuromodulation Devices Market, Asia-Pacific, Volume (Units), 2018-2033

Figure 4: Neuromodulation Devices Market, Asia-Pacific, Volume (Units), 2018-2033

Figure 5: Neuromodulation Devices Market, Asia-Pacific, Company Share (%), 2025

Figure 6: Neuromodulation Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033

Figure 7: Implantable Neuromodulation Devices Market, Australia, Revenue ($m), USD Constant, 2018-2033

Figure 8: Neuromodulation Devices Market, Australia, Volume (Units), 2018-2033

Figure 9: Implantable Neuromodulation Devices Market, Australia, Volume (Units), 2018-2033

Figure 10: Neuromodulation Devices Market, Australia, Company Share (%), 2025

Figure 11: Neuromodulation Devices Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 12: Implantable Neuromodulation Devices Market, China, Revenue ($m), USD Constant, 2018-2033

Figure 13: Neuromodulation Devices Market, China, Volume (Units), 2018-2033

Figure 14: Implantable Neuromodulation Devices Market, China, Volume (Units), 2018-2033

Figure 15: Neuromodulation Devices Market, China, Company Share (%), 2025

Figure 16: Neuromodulation Devices Market, India, Revenue ($m), USD Constant, 2018-2033

Figure 17: Implantable Neuromodulation Devices Market, India, Revenue ($m), USD Constant, 2018-2033

Figure 18: Neuromodulation Devices Market, India, Volume (Units), 2018-2033

Figure 19: Implantable Neuromodulation Devices Market, India, Volume (Units), 2018-2033

Figure 20: Neuromodulation Devices Market, India, Company Share (%), 2025

Figure 21: Neuromodulation Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033

Figure 22: Implantable Neuromodulation Devices Market, Japan, Revenue ($m), USD Constant, 2018-2033

Figure 23: Neuromodulation Devices Market, Japan, Volume (Units), 2018-2033

Figure 24: Implantable Neuromodulation Devices Market, Japan, Volume (Units), 2018-2033

Figure 25: Neuromodulation Devices Market, Japan, Company Share (%), 2025

Figure 26: Neuromodulation Devices Market, South Korea, Revenue ($m), USD Constant, 2018-2033

Figure 27: Implantable Neuromodulation Devices Market, South Korea, Revenue ($m), USD Constant, 2018-2033

Figure 28: Neuromodulation Devices Market, South Korea, Volume (Units), 2018-2033

Figure 29: Implantable Neuromodulation Devices Market, South Korea, Volume (Units), 2018-2033

Figure 30: Neuromodulation Devices Market, South Korea, Company Share (%), 2025

Asia-Pacific Neuromodulation Devices Market Outlook to 2033 – Implantable Neuromodulation Devices and Non-Invasive Neuromodulation Devices standard reports

Currency USD

Single User

$5,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Neurology Devices reports

Medical Devices

New

Regulatory Approved Apps Market Size by Segments, Share, Regulatory, Reimbursement,…

Medical Devices

New

Non-Invasive Ventilation Masks and Circuits Market Size by Segments, Share,…

Medical Devices

New

Insulin Pumps and Continuous Glucose Monitors Market Size by Segments,…

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Asia-Pacific Neuromodulation Devices Market Outlook to 2033 – Implantable Neuromodulation Devices and Non-Invasive Neuromodulation Devices in real time.

Access a live Asia-Pacific Neuromodulation Devices Market Outlook to 2033 – Implantable Neuromodulation Devices and Non-Invasive Neuromodulation Devices dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

Asia-Pacific Neuromodulation Devices Market Outlook to 2033 – Implantable Neuromodulation Devices and Non-Invasive Neuromodulation Devices

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports